Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Encompass Health Corporation

Stage 2 · Advancing · week 11

As of Oct 22, 2026, Encompass Health is in Stage 2, the uptrend phase, now in week 11 (since Aug 7, 2026). It closed at $126.01, 1.5% below its 52-week high and above its 200-day average, which is rising.

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. More about the company

$126.01
+4.60% today
$12.4B · Large cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 17 in Medical Care Facilities · #1 of 272 in Health Care

Is EHC early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 53w
S2 19w
S4 16w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 9w → S3 11w → S2 53w → S3 9w → S2 19w → S3 5w → S2 10w → S3 6w → S4 16w → S1 4w → S4 3w → S1 4w → S4 2w → S1 3w → S2 11w current
Total tracked: 165 weeks across 15 stage runs.

EHC among Medical Care Facilities26th of 49 by relative strength

All 49 →
Stocks in Medical Care Facilities ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AGLStage 3 · wk 898+6.8%
2PACSStage 3 · wk 498+15.7%
3LFSTStage 2 · wk 2497+4.0%
4AMNStage 2 · wk 2596+38.1%
5NHCStage 2 · wk 5995+8.4%
6CONStage 2 · wk 2294+14.9%
7INNVStage 3 · wk 593+5.8%
8MDStage 2 · wk 2692+14.3%
…26EHCStage 2 · wk 1155+3.3%
vs 52W High
-1.5%
$93.31 lo$127.87 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 11
1w13w26w
Week 11, early Stage 2
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
15.6%
200 DMA: $108.99 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
1.32x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
Short-term trend rising gently
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+3.3%
3M
+11.8%
6M
+24.2%
YTD
+19.1%
1Y
+1.6%
Scan Membership
Breakout Watch
Latest: 2025-03-17
11 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 11 · Vol 1.32x
2026-10-21S2
Wk 11 · Vol 1.23x
2026-10-20S2
Wk 11 · Vol 1.49x
2026-10-19S2
Wk 11 · Vol 2.50x
2026-10-16S2
Wk 10 · Vol 1.41x
2026-10-15S2
Wk 10 · Vol 1.20x
2026-10-14S2
Wk 10 · Vol 0.79x
2026-10-13S2
Wk 10 · Vol 0.64x
2026-10-12S2
Wk 10 · Vol 1.14x
2026-10-09S2
Wk 9 · Vol 0.65x
2026-10-08S2
Wk 9 · Vol 0.97x
2026-10-07S2
Wk 9 · Vol 0.94x
Moving averages & range
50 DMA
$122.20
200 DMA
$108.99
52W High
$127.87
52W Low
$93.31
5D Low
$120.47
Resistance levels (recent highs)
20d High
$127.87
60d High
$127.87
120d High
$127.87
250d High
$127.87
Next resistance
+1.5%
to 20d High
P/E (TTM)
21.1
Forward 18.9
Earnings Growth (YoY)
+10.8%
Revenue +9.6%
ROE
+25.0%
Profit margin +10.0%
Dividend Yield
0.70%
P/B 4.8

Encompass Health: quick answers

What stage is Encompass Health in?

As of Oct 22, 2026, Encompass Health (EHC) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 7, 2026 and is in week 11. What the four stages mean

Is Encompass Health in an uptrend?

Yes. Encompass Health is in a Stage 2 uptrend. It trades 15.6% above its 200-day average, which is rising.

How far is Encompass Health from its 52-week high?

Encompass Health closed at $126.01 on Oct 22, 2026, 1.5% below its 52-week high of $127.87. Its 52-week low is $93.31.

How has Encompass Health performed over the past year?

As of Oct 22, 2026, Encompass Health is up 1.6% over the past year and up 19.1% so far in 2026.

Which sector and industry is Encompass Health in?

Encompass Health is in the Medical Care Facilities industry, part of the Health Care sector.

About this companyHealth Care· Medical Care Facilities

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.